The future direction of neuro-urology drug research

Current Opinion in Central and Peripheral Nervous System Investigational Drugs

Volumn 2, Issue 3, 2000, Pages 268-282

  Steers, W D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Autonomic nervous system; BPH; Erectile dysfunction; Incontinence; Smooth muscle

Indexed keywords

3 [3 [4 [4 FLUORO 2 (2,2,2 TRIFLUOROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 5 METHYL 1H PYRIMIDINE 2,4 DIONE; 3 BENZYL 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 2 BUTENOIC ACID; 4 (3,4 DIFLUOROPHENYL) 3,4 DIHYDRO 6 METHOXYMETHYL 2(1H) OXO 3,5 PYRIMIDINEDICARBOXYLIC ACID 5 METHYL ESTER 3 [3 [4 (2 PYRIDYL) 1 PIPERIDINYL]PROPYL]AMIDE; 5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROSTANOLONE; APOMORPHINE; BETHANECHOL; BOTULINUM TOXIN A; DOXAZOSIN; ENDOTHELIN; FIDUXOSIN; FINASTERIDE; GL 198745; L 771688; NERVE GROWTH FACTOR AGONIST; NITRIC OXIDE; PERGOLIDE; PERGOLIDE MESILATE; PHOSPHODIESTERASE INHIBITOR; PRAZOSIN; SC 113; SEROTONIN 4 AGONIST; SILDENAFIL; SILODOSIN; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN; TIZANIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ASTHENIA; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC NERVE; CHOLINERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; DETRUSOR DYSSYNERGIA; DIABETES MELLITUS; DRUG RESEARCH; ERECTILE DYSFUNCTION; GALLBLADDER EMPTYING; HUMAN; PHASE 2 CLINICAL TRIAL; PROSTATE HYPERTROPHY; REVIEW; SMOOTH MUSCLE; URINE FLOW RATE; URINE INCONTINENCE; URINE RETENTION; VERTIGO;

EID: 0033936877     PISSN: 1464844X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (171)